Boston Scientific Corporation (BSX)
Company Info
| ISIN | US1011371077 |
|---|---|
| CUSIP | 101137107 |
| Sector | Healthcare |
| Industry | Medical Devices |
Highlights
| Market Cap | $98.97B |
|---|---|
| EPS | $1.07 |
| PE Ratio | 62.93 |
| PEG Ratio | 1.80 |
| Revenue (TTM) | $14.24B |
| Gross Profit (TTM) | $8.68B |
| EBITDA (TTM) | $3.61B |
| Year Range | $48.35 - $69.21 |
| Target Price | $73.75 |
| Short % | 0.85% |
| Short Ratio | 2.01 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BSX vs. BDX, BSX vs. STE, BSX vs. VTI, BSX vs. SNN, BSX vs. GLDM, BSX vs. XLV, BSX vs. IHI, BSX vs. SPY, BSX vs. SLG, BSX vs. VOO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Boston Scientific Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Boston Scientific Corporation had a return of 19.34% year-to-date (YTD) and 34.38% in the last 12 months. Over the past 10 years, Boston Scientific Corporation had an annualized return of 17.86%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 19.34% | 6.30% |
| 1 month | 2.03% | -3.13% |
| 6 months | 35.38% | 19.37% |
| 1 year | 34.38% | 22.56% |
| 5 years (annualized) | 13.35% | 11.65% |
| 10 years (annualized) | 17.86% | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 9.43% | 4.66% | 3.44% | |||||||||
| 2023 | -2.11% | -3.05% | 9.18% | 3.44% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Boston Scientific Corporation(BSX)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Boston Scientific Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Boston Scientific Corporation was 89.15%, occurring on Jul 26, 2012. Recovery took 2268 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -89.15% | Apr 6, 2004 | 2093 | Jul 26, 2012 | 2268 | Aug 2, 2021 | 4361 |
| -73.66% | Jul 19, 1999 | 353 | Dec 6, 2000 | 570 | Mar 20, 2003 | 923 |
| -58.38% | Jan 27, 1993 | 177 | Oct 7, 1993 | 361 | Mar 14, 1995 | 538 |
| -47.77% | Aug 20, 1998 | 57 | Nov 9, 1998 | 89 | Mar 19, 1999 | 146 |
| -46.02% | Aug 7, 1997 | 95 | Dec 19, 1997 | 134 | Jul 6, 1998 | 229 |
Volatility
Volatility Chart
The current Boston Scientific Corporation volatility is 3.69%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |